Supplemental Material and Methods: Reagents, antibodies, and cell lines: Myc-SKD1 WT and mutant (E235Q) constructs were provided by P. Hanson (Washington University School of Medicine). Eps15WT-FLAG, Eps15Y850F-FLAG and Eps15-E29-eGFP constructs were provided by W. Atwood (Brown University). HA-Rab11WT, HA-Rab11S20V (Rabll CA), and HA-Rab11S25N (Rabll DN) constructs were provided by M. Marks (University of Pennsylvania). GFP-HA-PIKfyveWT and GFP-HA-PIKfyve K1831E (PIKfyve DN) constructs were provided by A. Shisheva (Wayne State University School of Medicine). Myc-Rab7WT and Myc-Rab7Q67L (Rab7 CA) constructs were provided by C. Bucci (Universita del Salento, Italy). Rab7T22N (Rab7 DN) and anti-Rab7 antibody was provided by A. Waddinger-Ness (University of New Mexico). Myc-Raptor was purchased from Addgene. Myc-hVps34/hVps15-V5 as described previously (Yan et al., 2009 ) . Anti-GFP antibody was purchased from BabCo. Goat anti-Myc antibody was purchased from Santa Cruz Biotechnology. Anti-pT172 AMPK antibody was purchased from Cell Signaling technology. Anti-Flag antibody, 2-Deoxyglucose, and recombinant human insulin were purchased from Sigma. [ 3 H]-L-Leucine was purchased from Perkin Elmer (Waltham, Ma) and [ 3 H]-2-Deoxyglucose (2-DG) was purchased from Dupont NEN (Newton, MA).
serum free DMEM, rapidly warmed to 37° C and incubated for 60 min in serum free DMEM. Cells were fixed and immunostained for overexpressed Rab7 and PDGFR. Nutrient Uptake Assays: To measure leucine uptake, Hela cells grown in 6-well plates were washed and then incubated in warm uptake buffer (10 nM L-Leucine, 135 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 10 mM Glucose, 2 mM Glutamine, 20 mM HEPES (pH 7.5)) at 37° C for 5 minutes. To each well, buffer containing 1 μCi of [ 3 H]-L-Leucine and either 50 μM cold L-Leucine or 10 mM cold L-Leucine (for non specific uptake) was added. At various times, uptake was terminated by four quick washes in ice-cold PBS followed by 10 minute solubilization at 37° C in 0.5 ml/well 0.1 N NaOH. Uptake was quantitated by liquid scintillation counting. Specific uptake was calculated by subtracting non-specific uptake at each time point. To evaluate effect of Rab5 CA on leucine uptake, Hela cells grown in 6-well plates were transfected with empty vector or Rab5CA using TransIT HeLa Monster kit, and uptake during a 1 min incubation was measured as described above. The Micro-BCA assay kit (Pierce Biotechnology, Waltham, MA) was used to calculate total amount of protein. Parallel plates were used for whole cell lysate collection and western blotting to determine Rab5 expression levels and effect of Rab5 CA on amino acid stimulated endogenous pS6K1.
To measure glucose uptake, Hela cells grown on 6-well plates were washed 2 times in PBS and once in 0.1% BSA/DMEM, and incubated with 2 ml/well 0.1% BSA/DMEM for 2 hrs at 37° C. Cells were then incubated in warm KRPH buffer (5 mM Na2HPO4 (pH 7.4), 20 mM HEPES (pH 7.4), 1 mM MgSO4, 136 mM NaCl, 1% BSA, 1 mM CaCl2, 4.7 mM KCl) for 20 mins at 37° C. The cells were placed on ice and the buffer replaced with 1 ml/well ice-cold KRPH containing 1 μCi [ 3 H]-2-DG and 1 mM cold 2-DG on ice. After various times, uptake was terminated by the addition of 1 ml/well KRPH containing 20 μM Cytochalasin B, followed by three quick washes in icecold PBS and 10 minute solubilization at 37° C in 0.5 ml/well 0.1 N NaOH. Uptake was quantitated by liquid scintillation counting. To evaluate effect of Rab5 CA on glucose uptake, Hela cells grown in 6-well plates were transfected with empty vector or Rab5CA using TransIT HeLa Monster kit, and uptake during a 5 min incubation was measured as described above. The Micro-BCA assay kit (Pierce Biotechnology) was used to calculate total amount of protein. Parallel plates were used for whole cell lysate collection and western blotting to determine Rab5 expression levels and effect of Rab5 CA on insulin stimulated endogenous pS6K1.
Myc-Raptor and endogenous mTOR coimmunoprecipitation:
HEK293T cells grown in 10 cm tissue culture dishes were cotransfected with Myc-Raptor and empty vector or Rab5CA using Fugene HD. Cells were washed with PBS and lysed in CHAPS lysis buffer as described (Kim et al., 2002) . Anti-Myc immunoprecipitates and whole cell lysates were used for western blot analysis of endogenous mTOR, Myc-Raptor, and Rab5CA levels.
Supplemental Figures:
Supplemental Figure 1 : Inhibition of clathrin-dependent endocytosis, endocytic recycling, or endosome to TGN recycling does not affect insulin-stimulated S6K1 activation. A) Overexpression of Eps15-E29 blocks internalization of Cy3-labelled transferrin. To inhibit clathrin mediated endocytosis, we used dominant negative Eps15 constructs (Querbes et al., 2004) . Eps15 is involved in the assembly of AP-2 and clathrin on the plasma membrane during the formation of clathrin coated pits, and is required for clathrin-dependent endocytosis (van Delft et al., 1997; Benmerah et al., 1998) . Deletion of amino acids 95-295, which eliminates the EH2 domain of Eps15 (Eps15-ΔE95), blocks both constitutive and ligand-stimulated endocytosis, whereas a point mutation (Y850F) blocks only ligand inducible clathrin-dependent endocytosis (Querbes et al., 2004) . HeLa cells were transfected with either GFP control or GFP-Eps15-DEH95. Cy3-Tf (20 µg/ml) uptake was carried out for 15 min. Cells were washed and fixed as described in methods. Arrows indicate transfected cells. 5 μm scale bars are shown. B) Overexpression of Eps15 WT, Eps15Y850F, or Eps15-ΔE95 has no effect on S6K1 activation in insulin-stimulated cells. HEK293E cells were transfected with HA-S6K1 and either empty vector, Eps15 WT-FLAG, Eps15-Y850F-FLAG, or GFP-Eps15-DEH95 constructs as indicated. Serum starved cells were incubated without or with 1 µM human insulin for 30 min. Anti-HA immunoprecipitates or cleared lysates were blotted for pT389-S6K1, total S6K1, FLAG and GFP. C) Overexpression of Rab11DN, but not Rab11WT or Rab11CA, leads to decreased endocytic recycling of cy3-labelled transferrin. To inhibit endocytic recycling we used mutants of Rab11, which regulates trafficking of membrane proteins from endosomes and the recycling compartments back to the plasma membrane. Inhibition of Rab11 signaling through a S25N mutation (Rab11DN) leads to a decrease in endocytic recycling and a build up of internalized proteins in endosomes and recycling compartments (Ren et al., 1998) . HeLa cells were transfected with wild type and mutant Rab11 constructs as indicated. Cy3-Tf uptake was carried out for 30 min, and the cells were then washed two times and incubated in presence of desferoxamine at 37° C for 30 min. The cells were fixed and immunostained for HA (to visualize Rab11). Arrows indicate transfected cells. 5 μm scale bars are shown. D) Overexpression of these Rab11 mutants has no effect on activation of S6K1 in insulin-stimulated cells. HEK293E cells were transfected with HA-S6K1 and either empty vector or wild type and mutant Rab11 constructs as indicated. Serum starved cells were incubated without or with 1 µM human insulin for 30 min. Anti-HA immunoprecipitates or cleared lysates were blotted for pT389-S6K1, total S6K1, and HA (Rab11). E) Overexpression of PIKfyveDN, but not PIKfyveWT, leads to the enlargement of late endosomes. To inhibit endosome to TGN recycling we used a dominant negative mutant of PIKfyve, a PI[3]P-5-kinase. PIKfyve is recruited to endosomes through its FYVE domain, which binds to PI[3]P (Sbrissa et al., 2002) . Inhibition of PIKfyve lipid kinase activity through a K1831E mutation (PIKfyve DN) blocks endosome to TGN recycling and leads to a swelling of late endosomes (Ikonomov et al., 2001; Ikonomov et al., 2003; Ikonomov et al., 2009) . HeLa cells were transfected with either GFP-HA-PIKfyve-WT or GFP-HA-PIKfyve-DN (PIKfyve K1831E; dominant negative, kinase-deficient) as indicated. Cells were fixed and immunostained for endogenous LAMP-2. Arrows indicate transfected cells. 5μm scale bars are shown. F) Overexpression of PIKfyveWT or PIKfyveDN has no effect on insulin stimulation of S6K1. HEK293E cells were transfected with HA-S6K1 and either empty vector, GFP-HA-PIKfyve-WT or GFP-HA-PIKfyve-DN constructs as indicated. Serum starved cells were incubated without or with 1 µM human insulin for 30 min. Anti-HA immunoprecipitates or cleared lysates were blotted for pT389-S6K1, total S6K1, and HA (PIKfyve).
Supplemental Figure 2: Inhibition of multivesicular body biogenesis or late endosome to lysosome trafficking does not affect insulin-stimulated S6K1 activation. A)
Overexpression of SKD1-EQ, but not SKD1-WT, leads to the enlargement of late endosomes. To inhibit MVB biogenesis, we used a dominant negative mutant of SKD1 (Vps4p in yeast), which associates with late endosomes by binding to ESCRT complexes II and III (Lin et al., 2005) . SKD1 is an AAA ATPase, and it causes the disassembly of ESCRT complexes from late endosomes, thereby allowing continual rounds of multivesicular body biogenesis to occur (Babst, 2005) . Inhibition of SKD1 ATPase activity through a E235Q mutation (SKD1-EQ) leads to a block in multivesicular body biogenesis, leading to a build up of ubiquitinated proteins at swollen late endosomal membranes (Lin et al., 2005) . HeLa cells were transfected with either Myc-SKD1-WT or Myc-SKD1-EQ. 24 hrs after transfection, cells were fixed and immunostained for endogenous LAMP-2 and Myc (to visualize SKD1). Arrows indicate transfected cells. 10 μm scale bars are shown B) Overexpression of wild type or mutant SKD1 has no effect on insulin stimulation of S6K1. HEK293E cells were transfected with HA-S6K1 and either empty vector, Myc-SKD1-WT, or Myc-SKD1-EQ constructs as indicated. 24 hrs post transfection, serum starved cells were incubated without or with 1 µM human insulin for 30 min. Anti-HA immunoprecipitates and anti-Myc immunoprecipitates were blotted for pT389-S6K1, total S6K1, and Myc (SKD1). C) Overexpression of Rab7 DN, but not Rab7 WT or Rab7 CA, leads to decreased lysosomal degradation of transfected PDGF receptors. To inhibit late endosome to lysosome fusion we used the dominant negative Rab7-T22N mutant (Rab7 DN). This construct leads to a block of late endosomelysosome fusion and a build up in late endosomes of proteins that were targeted for degradation, such as growth factor receptors (Vitelli et al., 1997) . HeLa cells were transfected with human PDGFR and either empty vector, Myc-Rab7WT, Rab7DN, or Myc-Rab7CA as indicated. Serum starved cells were incubated on ice with 20ng/ml PDGF-BB and 5 µg/ml mouse anti-human PDGFR, washed, then rapidly warmed to 37° C and incubated for 60 min. Cells were fixed and immunostained for overexpressed Rab7 and PDGFR. 5 μm scale bars are shown. D) Overexpression of Rab7 WT, Rab7 DN or Rab7 CA has no effect on insulin-stimulated mTORC1/S6K1 signaling. HEK293E cells were transfected with HA-S6K1 and either empty vector, Myc-Rab7WT, Rab7DN, or Myc-Rab7CA constructs as indicated. Serum starved cells were incubated without or with 1 µM human insulin for 30 min. Anti-HA immunoprecipitates or cleared lysates were blotted for pT389-S6K1, total S6K1, and Rab7.
Supplemental Figure 3: Overexpression of Rab5 CA does not inhibit leucine or glucose uptake. A)
Hela cells grown in 6-well plates were washed and incubated with [ 3 H]-Leucine for various times as described in methods. 0.1 N NaOH solubilized cells were measured by scintillation counting for [ 3 H]-Leucine uptake. Graph represents specific leucine uptake in pmoles/well at the indicated times. Data represent mean +/-S.E.M. of 4 replicates. B) Hela cells grown in 6-well plates transiently transfected with either empty vector or Rab5 CA constructs were washed and incubated with [ 3 H]-Leucine for 1 minute. Graph represents specific leucine uptake in pmoles/mg. Data represent mean +/-S.E.M. of 4 replicates. C) A parallel plate of Hela cells transfected at same time and conditions as in (B), were incubated in amino acid free media for 50 min then stimulated without or with 1X (final) complete amino acid solution for 30 min. Whole cell lysates were blotted for endogenous pT389 S6K1, Total S6K1, and overexpressed Rab5 as indicated. D) Hela cells grown in 6-well plates were washed and incubated with [ 3 H]-2-DG for various times as described in methods. 0.1 N NaOH solubilized cells were measured by scintillation counting for [ 3 H]-2-DG uptake. Graph represents specific glucose uptake in pmoles/well. at the indicated times. Data represent mean +/-S.E.M. of 4 replicates. E) Hela cells grown in 6-well plates transiently transfected with either empty vector or Rab5 CA constructs were washed and incubated with [ 3 H]-2-DG for 5 minutes. Graph represents specific activity of leucine uptake in pmoles/mg. Data represent mean +/-S.E.M. of 6 replicates. F) A parallel plate of Hela cells transfected at same time and conditions as in (E) were serum starved overnight then stimulated without or with 1μM human Insulin for 30 min. Whole cell lysates were blotted for endogenous pT389 S6K1, Total S6K1, and overexpressed Rab5 as indicated.
Supplemental Figure 4:
Overexpression of Rab5CA does not inhibit mTORC1 stability or upstream signaling to mTORC1, and cannot be rescued by overexpression hVps34/hVps15. A) HEK293E cells were transfected with either empty vector or Rab5 CA as indicated. Cells were either serum starved overnight then stimulated without or with 1 μM human insulin for 30 minutes, or serum starved for 45 minutes then treated with 25 mM 2-DG for 15 minutes. Whole cell lysates were probed for endogenous pT172 AMPK, pT389 S6K1, pT308 Akt, GAPDH, and overexpressed Rab5 as indicated. B) HEK293T cells were transfected with Myc-Raptor and either empty vector or Rab5CA as indicated. Cells were lysed in CHAPS lysis buffer and anti-Myc immunoprecipitates or cleared lysates from each condition were blotted with the indicated antibodies. C) HEK239E cells were transfected with HA-S6K1 and with combinations of empty vector, Myc-hVps34/hVps15-V5 and Rab5CA, as indicated. Serum starved cells were incubated without or with 1 µM human insulin for 30 min. Anti-HA immunoprecipitates or cleared lysates from each condition were blotted for pT389-S6K1, total S6K1, V5, Myc, and Rab5 as indicated. 
